Following news that an announcement regarding the future location of the European Medicines Agency (EMA) will be delayed until the European Commission's General Affairs Council in November 2017, the Association of the British Pharmaceutical Industry (ABPI) have issued the following statement.
A joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published today by the Financial Times, has outlined the UK Government’s plans for the regulation of medicines as the UK leaves the European Union (EU).
The Chief Executive of The Association of the British Pharmaceutical Industry (ABPI), alongside leaders from seven other UK and European pharmaceutical and life science industry bodies, have written a joint letter to both the UK and EU Brexit negotiation teams to underline the importance of securing...
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union.
The ABPI and the BIA have welcomed the UK Government’s latest Brexit position paper on ‘Collaboration on science and innovation’.
To coincide with today’s House of Commons Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have published new research on the public...
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss says a new review article published in Frontiers in Medicine, written by Association of the...
The report published today by the Academy of Medical Sciences describes an urgent and serious challenge about how we ensure that patients, their carers and the healthcare professionals that support them, feel able to trust their medicines and the research evidence that underpins them.
The Government has today [13 July] published new data on the use of animals in the research and development of medicines in the UK. These annual statistics relating to scientific procedures performed on living animals are published in accordance with the Animals (Scientific Procedures) Act 1986.
The Life Sciences Industrial Strategy, supported by Government and led by Sir John Bell, has been launched today in Birmingham.